Structure of bone morphogenetic protein 9 procomplex

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 12, 2015, Pages 3710-3715

  Mi, Li Zhi ^a,b,c   Brown, Christopher T ^d   Gao, Yijie ^d   Tian, Yuan ^a,b   Le, Viet Q ^a,b   Walz, Thomas ^a,e   Springer, Timothy A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c TIANJIN UNIVERSITY   (China)

^d PFIZER INC   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 8; BONE MORPHOGENETIC PROTEIN 9; GROWTH DIFFERENTIATION FACTOR 15; GROWTH DIFFERENTIATION FACTOR 5; GROWTH DIFFERENTIATION FACTOR 6; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BMP7 PROTEIN, HUMAN; GDF2 PROTEIN, HUMAN; GROWTH DIFFERENTIATION FACTOR; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; GLYCOSYLATION; HYDROPHOBICITY; INDEL MUTATION; LATENT PERIOD; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; RECEPTOR BINDING; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; HAMSTER; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CHO CELLS; CRICETINAE; CRICETULUS; GROWTH DIFFERENTIATION FACTORS; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84925432612     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1501303112     Document Type: Article

References (26)

1. Wang EA, et al. (1988) Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85(24):9484-9488.
2. Luyten FP, et al. (1989) Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 264(23):13377-13380.
3. Celeste AJ, et al. (1990) Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87(24):9843-9847.
4. Cui Y, et al. (2001) The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev 15(21):2797-2802.
5. Harrison CA, Al-Musawi SL, Walton KL (2011) Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands. Growth Factors 29(5):174-186.
6. Constam DB (2014) Regulation of TGFβ and related signals by precursor processing. Semin Cell Dev Biol 32:85-97.
7. Akiyama T, Marqués G, Wharton KA (2012) A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing. Sci Signal 5(218):ra28.
8. Gregory KE, et al. (2005) The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J Biol Chem 280(30):27970-27980.
9. Sengle G, Ono RN, Sasaki T, Sakai LY (2011) Prodomains of transforming growth factor β (TGFβ) superfamily members specify different functions: Extracellular matrix interactions and growth factor bioavailability. J Biol Chem 286(7):5087-5099.
10. Shi M, et al. (2011) Latent TGF-β structure and activation. Nature 474(7351):343-349.
11. Bidart M, et al. (2012) BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain. Cell Mol Life Sci 69(2):313-324.
12. Chen H, et al. (2013) Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc Natl Acad Sci USA 110(29):11887-11892.
13. Castonguay R, et al. (2011) Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem 286(34):30034-30046.
14. David L, Feige JJ, Bailly S (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20(3):203-212.
15. Wooderchak-Donahue WL, et al. (2013) BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93(3):530-537.
16. Brown MA, et al. (2005) Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280(26):25111-25118.
17. Townson SA, et al. (2012) Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex. J Biol Chem 287(33):27313-27325.
18. Sengle G, Ono RN, Lyons KM, Bächinger HP, Sakai LY (2008) A new model for growth factor activation: Type II receptors compete with the prodomain for BMP-7. J Mol Biol 381(4):1025-1039.
19. Scharpfenecker M, et al. (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120(Pt 6):964-972.
20. Zhang JL, et al. (2008) Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev Cell 14(5):739-750.
21. Sengle G, et al. (2008) Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 283(20):13874-13888.
22. Li S, et al. (2010) Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity. J Biol Chem 285(47):36645-36655.
23. Anderson SB, Goldberg AL, Whitman M (2008) Identification of a novel pool of extracellular pro-myostatin in skeletal muscle. J Biol Chem 283(11):7027-7035.
24. Pietrzak WS, Woodell-May J, McDonald N (2006) Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix. J Craniofac Surg 17(1):84-90.
25. Seidah NG, Prat A (2012) The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov 11(5):367-383.
26. Krissinel E, Henrick K (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1):2256-2268.